EMBO invited its 1800 Members and 150 Young Investigators to report on any efforts they or their institutions are making to help fight the ongoing COVID-19 pandemic.
Information for EMBO Fellows, organisers of EMBO events and authors of papers submitted to EMBO Press
The spread of the novel coronavirus (SARS-CoV-2) is continuing to quickly evolve in many countries. EMBO is continuing to monitor the situation closely to help prevent potential health and financial impact from the outbreak on EMBO Fellows, organizers of EMBO-funded events and the participants, and EMBO staff.
On 7-11 December 2019, the annual ASCB|EMBO Meeting took place in Washington DC, USA. The meeting brings together life scientists from around the world.
EMBO has removed the 40-year age limit from the eligibility criteria for the Young Investigator Programme.
Although the United Kingdom is leaving the European Union today, scientists based in the UK will continue to have access to all EMBO Programmes and activities.
EMBO Molecular Medicine (EMM), one of five journals published by EMBO Press, was established in 2009 for the purpose of publishing the best work at the interface between clinical research and molecular cell biology. In its tenth anniversary year, we highlight ten characteristics that have helped to establish EMM in the world of scientific publishing.
Peer Review Week, a series of events to highlight the essential role of peer review in scientific publishing, takes place for the fifth time this year. This year’s focus on quality in peer review offers an opportunity for EMBO Press to celebrate a decade of transparent peer review.